Duke Center for Cancer Immunotherapy — Raleigh, North Carolina

Duke Center for Cancer Immunotherapy is a clinical research site located in Raleigh, North Carolina, United States 27710.

Crixeo Health Trust Score: 41/100 (POOR). This profile has not yet been claimed by the site owner.

Duke Center for Cancer Immunotherapy has participated in 1 clinical trials.

Therapeutic areas: Metastatic Non Small Cell Lung Cancer.

Sponsors: AbelZeta Inc..

Sponsor Feasibility Report

Trust Score: 41/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Duke Center for Cancer Immunotherapy?

Duke Center for Cancer Immunotherapy has a Crixeo Trust Score of 41/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Duke Center for Cancer Immunotherapy conducted?

Duke Center for Cancer Immunotherapy has 1 clinical trials on record. Their work covers Metastatic Non Small Cell Lung Cancer.

Is Duke Center for Cancer Immunotherapy accredited by Crixeo Health?

Duke Center for Cancer Immunotherapy has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Duke Center for Cancer Immunotherapy?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.